Literature DB >> 24243625

Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues.

Sarah J Holdsworth-Carson1, Marina Zaitseva, Beverley J Vollenhoven, Peter A W Rogers.   

Abstract

Uterine fibroids are conventionally defined as clonally derived benign tumours from the proliferation of a single smooth muscle cell (SMC). We have previously identified fibroblast-like cells in fibroids, the presence of which raises the question as to whether all cells within the fibroid have the same clonal origin. The first aim of this study was to develop a fluorescence-activated cell sorting (FACS)-based method to isolate different cell types from human myometrium and fibroid tissues. Secondly, we aimed to use X chromosome inactivation analysis to determine the clonality of cell subpopulations isolated from myometrial and fibroid tissues. Human myometrium and fibroid tissues were collected from women undergoing hysterectomy. Immunohistochemistry (IHC) and flow cytometry confirmed that in addition to SMCs, fibroblasts constitute a significant proportion of cells in human myometrium and fibroid tissues. FACS based on CD90 and ALDH1 reliably separated cells into three myometrial and four fibroid subpopulations: SMCs, vascular smooth muscle cells and two fibroblast subsets. Clonality was first determined by X chromosome inactivation using the classic DNA methylation-sensitive HUMARA assay. Data from this assay were highly variable, with only a quarter of samples meeting the definition of clonal fibroid and non-clonal myometrium. However, using an RNA-based X chromosome inactivation HUMARA assay, we were able to demonstrate clonality of all cellular constituents of most fibroids. Our results confirm that most fibroids are derived from a single cell, and for the first time demonstrates that these clonal cells differentiate into fibroblast and SMC subpopulation as the fibroid grows.

Entities:  

Keywords:  clonal; uterine fibroids

Mesh:

Substances:

Year:  2013        PMID: 24243625     DOI: 10.1093/molehr/gat083

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  25 in total

1.  Moving Toward Individualized Medicine for Uterine Leiomyomas.

Authors:  Shannon K Laughlin-Tommaso; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

Review 2.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

3.  Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties.

Authors:  Amanda L Patterson; Jitu W George; Anindita Chatterjee; Tyler J Carpenter; Emily Wolfrum; David W Chesla; Jose M Teixeira
Journal:  Hum Reprod       Date:  2020-01-01       Impact factor: 6.918

4.  A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Ben Davidson; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Sep-Oct       Impact factor: 3.395

5.  Mesenchymal Stem/Stromal Cells Derived From a Reproductive Tissue Niche Under Oxidative Stress Have High Aldehyde Dehydrogenase Activity.

Authors:  Gina D Kusuma; Mohamed H Abumaree; Mark D Pertile; Anthony V Perkins; Shaun P Brennecke; Bill Kalionis
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

6.  Subtype-Specific Tumor-Associated Fibroblasts Contribute to the Pathogenesis of Uterine Leiomyoma.

Authors:  Xin Wu; Vanida A Serna; Justin Thomas; Wenan Qiang; Michael L Blumenfeld; Takeshi Kurita
Journal:  Cancer Res       Date:  2017-10-20       Impact factor: 12.701

7.  Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.

Authors:  Aymara Mas; Sangeeta Nair; Archana Laknaur; Carlos Simón; Michael P Diamond; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2015-05-16       Impact factor: 7.329

8.  Contrast-Enhanced Ultrasound for Monitoring Non-surgical Treatments of Uterine Fibroids: A Systematic Review.

Authors:  Mehnoosh Torkzaban; Priscilla Machado; Ipshita Gupta; Yang Hai; Flemming Forsberg
Journal:  Ultrasound Med Biol       Date:  2020-10-22       Impact factor: 2.998

Review 9.  Emerging Roles of Long Non-coding RNAs in Uterine Leiomyoma Pathogenesis: a Review.

Authors:  Zahra Falahati; Masoud Mohseni-Dargah; Reza Mirfakhraie
Journal:  Reprod Sci       Date:  2021-04-12       Impact factor: 3.060

10.  The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.

Authors:  Elizabeth A Stewart; Barbara L Lytle; Laine Thomas; Ganesa R Wegienka; Vanessa Jacoby; Michael P Diamond; Wanda K Nicholson; Raymond M Anchan; Sateria Venable; Kedra Wallace; Erica E Marsh; George L Maxwell; Bijan J Borah; William H Catherino; Evan R Myers
Journal:  Am J Obstet Gynecol       Date:  2018-05-08       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.